• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A step backwards in the fight against global vaccine inequities.

作者信息

Aryeetey Ernest, Engebretsen Eivind, Gornitzka Åse, Maassen Peter, Stølen Svein

机构信息

The African Research Universities Alliance, Accra, Ghana.

University of Oslo, Oslo N-0316, Norway.

出版信息

Lancet. 2021 Jan 2;397(10268):23-24. doi: 10.1016/S0140-6736(20)32596-4. Epub 2020 Dec 9.

DOI:10.1016/S0140-6736(20)32596-4
PMID:33308424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7834406/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db5/7834406/7f25be81ef30/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db5/7834406/7f25be81ef30/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db5/7834406/7f25be81ef30/fx1_lrg.jpg

相似文献

1
A step backwards in the fight against global vaccine inequities.全球疫苗不平等斗争中的一次倒退。
Lancet. 2021 Jan 2;397(10268):23-24. doi: 10.1016/S0140-6736(20)32596-4. Epub 2020 Dec 9.
2
Intellectual property waiver for covid-19 vaccines will advance global health equity.新冠疫苗的知识产权豁免将推动全球卫生公平。
BMJ. 2021 Aug 3;374:n1837. doi: 10.1136/bmj.n1837.
3
Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic.共享技术和疫苗剂量以解决全球疫苗不平等问题并终结新冠疫情。
JAMA. 2021 Jul 20;326(3):219-220. doi: 10.1001/jama.2021.10823.
4
Suspend intellectual property rights for covid-19 vaccines.暂停新冠疫苗的知识产权。
BMJ. 2021 May 28;373:n1344. doi: 10.1136/bmj.n1344.
5
[Access to anti-covid vaccines: research, development and role of patents.].[获得抗新冠疫苗：专利的研究、开发及作用。]
Recenti Prog Med. 2021 Jul-Aug;112(7):499-503. doi: 10.1701/3638.36184.
6
COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs.COVID-19 疫苗和治疗的民族主义：对低收入国家和实现可持续发展目标的挑战。
Glob Public Health. 2021 Mar;16(3):319-339. doi: 10.1080/17441692.2020.1860249. Epub 2020 Dec 15.
7
A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness.全球知识产权豁免仍有必要，以解决新冠肺炎和未来大流行防范的不公平问题。
Inquiry. 2022 Jan-Dec;59:469580221124821. doi: 10.1177/00469580221124821.
8
Ensuring fair distribution of COVID-19 vaccines: is an intellectual waiver the answer?确保新冠疫苗的公平分配：知识共享豁免是答案吗？
Lancet Respir Med. 2021 Jul;9(7):e64. doi: 10.1016/S2213-2600(21)00241-1. Epub 2021 May 21.
9
Time for Africa to future-proof, starting with COVID-19.非洲应从新冠疫情开始，为未来做好准备。
Lancet Infect Dis. 2022 Feb;22(2):151. doi: 10.1016/S1473-3099(22)00011-1. Epub 2022 Jan 13.
10
Access to COVID-19 vaccines: looking beyond COVAX.获得新冠疫苗：超越新冠疫苗全球获取机制（COVAX）的视角
Lancet. 2021 Mar 13;397(10278):941. doi: 10.1016/S0140-6736(21)00617-6.

引用本文的文献

1
An ethical analysis of vaccinating children against COVID-19: benefits, risks, and issues of global health equity.对儿童接种新冠疫苗的伦理分析：益处、风险及全球卫生公平问题
Wellcome Open Res. 2021 Nov 29;6:252. doi: 10.12688/wellcomeopenres.17234.2. eCollection 2021.
2
Vaccine production and supply need a paradigm change.疫苗生产和供应需要范式转变。
Can J Chem Eng. 2022 Aug;100(8):1670-1675. doi: 10.1002/cjce.24399. Epub 2022 May 4.
3
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.

本文引用的文献

1
The UK Government's Vaccine Taskforce: strategy for protecting the UK and the world.英国政府疫苗特别工作组：保护英国及全球的战略。
Lancet. 2021 Jan 2;397(10268):68-70. doi: 10.1016/S0140-6736(20)32175-9. Epub 2020 Oct 27.
口服瑞德西韦前药治疗可预防 SARS-CoV-2 在小鼠中的发病机制。
Sci Transl Med. 2022 May 4;14(643):eabm3410. doi: 10.1126/scitranslmed.abm3410.
4
Assessing Inequities in COVID-19 Vaccine Roll-Out Strategy Programs: A Cross-Country Study Using a Machine Learning Approach.评估新冠疫苗接种策略项目中的不平等现象：一项使用机器学习方法的跨国研究
Vaccines (Basel). 2022 Jan 26;10(2):194. doi: 10.3390/vaccines10020194.
5
Naphthoquine: A Potent Broad-Spectrum Anti-Coronavirus Drug In Vitro.萘喹酮：一种有效的广谱抗冠状病毒药物的体外研究
Molecules. 2022 Jan 21;27(3):712. doi: 10.3390/molecules27030712.
6
Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice.一种瑞德西韦口服核苷类似物对小鼠体内严重急性呼吸综合征冠状病毒2发病机制的治疗效果。
bioRxiv. 2021 Sep 17:2021.09.13.460111. doi: 10.1101/2021.09.13.460111.
7
Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma.是时候加快新冠疫苗生产了：大型制药公司放弃知识产权的必要性。
Ethics Med Public Health. 2021 Dec;19:100710. doi: 10.1016/j.jemep.2021.100710. Epub 2021 Aug 23.
8
What are the obligations of pharmaceutical companies in a global health emergency?在全球卫生紧急情况下，制药公司有哪些义务？
Lancet. 2021 Sep 11;398(10304):1015-1020. doi: 10.1016/S0140-6736(21)01378-7. Epub 2021 Aug 6.
9
Global mental health: the role of collaboration during the COVID-19 pandemic.全球心理健康：COVID-19大流行期间合作的作用。
Glob Ment Health (Camb). 2021 May 28;8:e20. doi: 10.1017/gmh.2021.20. eCollection 2021.
10
Vaccine Inequities, Intellectual Property Rights and Pathologies of Power in the Global Response to COVID-19.疫苗不平等、知识产权与全球应对新冠疫情中的权力病态
Int J Health Policy Manag. 2022 Dec 6;11(11):2773-2775. doi: 10.34172/ijhpm.2021.57. Epub 2021 May 26.